CVS’ Shuttered Clinical Trials Business Doesn’t Mean Decentralized Models Are Doomed, Exec Says

CVS Health is winding down its clinical trials business, with a full exit expected by December 31, 2024, the company confirmed to MedCity News. But decentralized clinical trials still have an important role to play, said Brian Weiss, CEO of Carebox.